Therefore, the PCAT6/miR-326/RohA axis is important in regulating the immune response of CCA macrophages, suggesting that PCAT6 may be a potential target for CCA immunotherapy (67). The gene discussed is PCAT6; the disease is cholangiocarcinoma.